Foot lesions associated with Pseudomonas cepacia.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003470:Culture Media; D004352:Drug Resistance, Microbial; D005534:Foot Diseases / Q000209:etiology* / Q000382:microbiology; D005845:Georgia; D006801:Humans; D008297:Male; D008887:Military Medicine; D011549:Pseudomonas / Q000187:drug effects / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000453:epidemiology*; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D013420:Sulfamethoxazole / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology; D014329:Tropical Climate
D000900:Anti-Bacterial Agents; D003470:Culture Media; D014295:Trimethoprim; D013420:Sulfamethoxazole